首页> 外文期刊>Journal of Heterocyclic Chemistry: The International Journal of Heterocyclic Chemistry >Isoxazolopyrimidinethione and Isoxazolopyridopyrimidinethione Derivatives: Key Intermediates for Synthesis of Novel Fused Triazoles as Potent 5-Reductase Inhibitors and Anti-Prostate Cancer
【24h】

Isoxazolopyrimidinethione and Isoxazolopyridopyrimidinethione Derivatives: Key Intermediates for Synthesis of Novel Fused Triazoles as Potent 5-Reductase Inhibitors and Anti-Prostate Cancer

机译:异恶唑基嘧啶硫酮和异恶唑烷吡啶并嘧啶硫酮衍生物:合成新型融合三唑作为有效的5-还原酶抑制剂和抗前列腺癌的关键中间体

获取原文
获取原文并翻译 | 示例
           

摘要

The arylideneisoxazolone derivative 1 is used for preparation of two different pyrimidinethiones 3 and 5 through interaction with thiourea and thiouracil, respectively. Compounds 3 and 5 were subjected to reaction with different hydrazonyl halides in basic medium to afford different triazolopyrimidines 9a, 9b, 9c, 9d, 9e, 9f, 9g, 9h and 13a, 13b, 13c, 13d, 13e, 13f, the structures were confirmed by their spectral and elemental analysis. All the newly synthesized products were screened against 5-reductase. Some of the newly synthesized compounds showed potent 5-reductase inhibition activities with good ED50.
机译:亚芳基异恶唑酮衍生物1用于分别通过与硫脲和硫尿嘧啶相互作用而制备两种不同的嘧啶硫酮3和5。使化合物3和5在碱性介质中与不同的酰肼卤化物反应,得到不同的三唑并嘧啶9a,9b,9c,9d,9e,9f,9g,9h和13a,13b,13c,13d,13e,13f。经其光谱和元素分析证实。所有新合成的产物均针对5-还原酶进行筛选。一些新合成的化合物显示出有效的5-还原酶抑制活性,并具有良好的ED50。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号